Why Pigmentation Keeps Coming Back in Indian Skin
There is a specific kind of defeat that belongs to this experience. You finish a serum. The marks fade. You think: finally. And then, three months later — sometimes two — the pigmentation is back. Sometimes in the same place. Sometimes somewhere new. And you find yourself asking whether the product stopped working, whether your skin is simply this way, or whether you missed something.
You did not miss something. The product probably did exactly what it said it would. The problem is what it said — and what the entire category says — is not actually the full answer.
Pigmentation in Indian skin is not primarily a removal problem. It is a recurrence problem. And those two framings require very different responses.
This page explains what pigmentation actually is, why Indian skin produces it so readily, what keeps triggering it, and why treating only the visible mark — without touching the cycle behind it — reliably produces improvement followed by return. It is not a quick-fix guide. It is an explanation. Because an explanation is what actually changes things.
What Pigmentation Actually Is
A specialised cell located at the base of the epidermis — the outermost living layer of skin — that produces melanin in response to biological signals. Melanocytes produce melanin in discrete packages called melanosomes, which are then transferred to the surrounding keratinocytes. As those keratinocytes migrate toward the skin surface over several weeks, the melanin travels with them and becomes visible as colour. In Fitzpatrick IV–VI skin, melanocytes are more reactive to a wider range of signals and respond more intensely than those in lighter phototypes.
Pigmentation is melanin. Melanin performs a protective function: it absorbs UV radiation and prevents deeper tissue damage. This is a normal process. The problem is not that melanin exists. The problem is that in Indian skin, the system that produces it can become chronically overactive — responding to signals it was never designed to interpret as threats.
The clinical term for pigmentation produced by inflammation, rather than by direct UV exposure, is post-inflammatory hyperpigmentation, or PIH. It is the most common form of hyperpigmentation in Fitzpatrick IV–VI skin — the classification range that covers most Indian, South Asian, and other melanin-rich skin tones. A pimple leaves a dark mark. A minor cut leaves a shadow. A skincare product that irritated your skin leaves a patch where it sat. These are all PIH. PIH is, at its core, a record of inflammatory events the skin has experienced.
But hyperpigmentation in Indian skin is not only PIH. Melasma — hormonally influenced, often appearing on the cheeks, upper lip, and forehead — is also disproportionately common in Indian skin. So is pigmentation driven by chronic environmental exposure: visible light, heat, pollution, friction. The mechanisms differ, but they share a common feature: in eumelanin-rich skin, any sustained signal to the melanocyte tends to produce more pigment, more persistently, than the same signal would in lighter skin.
Why Pigmentation Happens More Easily in Indian Skin
The same pimple that leaves a day of redness on lighter skin can leave six weeks of dark marking on Indian skin. Not because the pimple was worse. Because the melanocyte read the signal differently.
This is not about having more melanin. It is about melanin that responds differently — more readily, more intensely, and for longer.
The melanocytes in Fitzpatrick IV–VI skin are not more numerous than those in lighter skin. What is different is their reactivity. They respond to a wider range of signals, and they respond more intensely. This is the biological characteristic that makes Indian skin specifically prone to post-inflammatory hyperpigmentation, and the characteristic that most pigmentation products were not formulated around.
There is also a structural reason marks look different on Indian skin. The packages that carry melanin — melanosomes — are larger in melanin-rich skin, and they distribute widely through surrounding keratinocytes rather than clustering in one place. This is part of why a dark mark on Indian skin appears more intensely and takes longer to fade: the pigment is distributed throughout the cells migrating slowly toward the surface, not concentrated in a single layer the skin can shed quickly.
Eumelanin, the dominant form of melanin in darker skin, also degrades more slowly than pheomelanin, which predominates in lighter phototypes. Pigment laid down during an inflammatory event stays visible longer in Indian skin experiencing the same event as lighter skin.
These are biological characteristics, not flaws. Indian skin is not broken. It is operating exactly as it is built to. But these characteristics do mean that Indian skin has a lower threshold for producing pigmentation in response to insult, and a higher likelihood that pigment, once produced, will remain visible for an extended period. This is also why most pigmentation products underperform on Indian skin. They were not built around this biology.
The Different Triggers Behind Pigmentation
Treating the output of the system — visible pigment — without reducing the inputs that keep producing it is why the cycle restarts after treatment ends. Pigmentation in Indian skin is not caused by a single trigger. It is sustained by several, often simultaneously.
Post-Inflammatory Triggers
Post-inflammatory triggers are the most familiar. Acne is the most common — the inflamed follicle generates an immune response, and that immune response sends a signal to the melanocytes to ramp up production. The pimple resolves. The signal has already been sent. The mark stays.
Friction is another post-inflammatory trigger: repeated mechanical stress on the skin surface — from clothing, straps, tight fabrics, habitual contact — degrades the stratum corneum over time and generates localised inflammation. Even routine procedures that many Indian women do monthly — waxing, threading — generate enough inflammation to trigger pigmentation in reactive skin. Brief, localised, ordinary. And for this skin type, enough.
Environmental Triggers
Environmental triggers are less commonly discussed but particularly relevant for Indian skin. Visible light — specifically high-energy visible light, or HEV, in the blue and violet wavelengths — activates melanocyte signalling in melanin-rich skin through mechanisms separate from UV. Standard broad-spectrum sunscreen does not fully filter visible light, which is why some people with rigorous SPF habits still experience ongoing pigmentation.
Heat activates melanocytes through a completely separate pathway from UV — through what are called heat shock proteins. The melanocyte reads thermal stress as a threat and responds accordingly. This matters in the Indian context specifically: the climate, the kitchen, the commute. These are not edge cases. They are daily life, and sunscreen does not reach any of them. Urban air pollution contributes oxidative stress to the skin surface, triggering the same inflammatory cascade as UV radiation and leading to melanocyte activation through a different pathway.
Routine-Induced Triggers
Routine-induced triggers are the category most often missed — partly because the products responsible are the ones being recommended as treatments. Aggressive exfoliation — whether physical or chemical — removes not just dead surface cells but disrupts the lipid matrix of the stratum corneum. That disruption triggers an inflammatory response. Retinoids and high-concentration acids can produce the same result in reactive skin: the intended benefit (cellular turnover, pigmentation reduction) comes at the cost of barrier disruption and the inflammatory signalling that follows. In eumelanin-rich skin, that inflammatory signalling produces pigmentation. The product clearing the skin is, in some cases, continuing the very cycle it is trying to interrupt.
All of these triggers — post-inflammatory, environmental, and routine-induced — feed into the same downstream pathway: keratinocyte-to-melanocyte signalling, melanin synthesis, melanosome transfer, and pigment deposition. The pigment visible on the skin surface is the output of this signalling. The triggers are the inputs.
Why Pigmentation Keeps Coming Back
"The frame itself guarantees recurrence, because it never addresses what is producing the pigment."
The short answer: because the trigger has not been addressed.
When a depigmenting treatment works — and many do, for a time — what it is doing is suppressing melanin somewhere in the production chain. It might inhibit tyrosinase, the enzyme that triggers melanin synthesis. It may interrupt melanosome transfer from melanocyte to keratinocyte. It may accelerate surface cell turnover, bringing pigment to the surface and shedding it faster. These are all legitimate interventions. They reduce visible pigment. But none of them address the signal that told the melanocyte to produce more melanin in the first place.
The melanocyte has not forgotten the signal it received. More importantly: the inflammation that sent that signal often has not resolved either. It is still running in the background. In many cases — chronic acne, ongoing UV and visible light exposure, continued use of reactive actives, persistent environmental load — the signal is still arriving, continuously, while the treatment is working to suppress the response downstream. When treatment stops, the suppression stops. The signal, which was always there, produces pigment again.
This is not exactly a product failure. Most products do what they say. The category's problem is more fundamental: it has framed pigmentation as a pigment problem. So the solution it offers is pigment removal. And when removal stops, the pigment — produced by a cycle that was never interrupted — returns.
The Barrier–Inflammation–Pigmentation Cycle
Understanding the skin barrier is what makes the recurrence picture complete. It is also the part that most pigmentation conversations leave out entirely.
The stratum corneum is the outermost structural layer of the skin. Its lipid matrix — made of ceramides, cholesterol, and fatty acids arranged in organised lamellar layers — has two functions: keep water in and keep environmental irritants out. When this structure is intact, the skin maintains its homeostasis reasonably well. When it is disrupted, the consequences extend far beyond dryness.
A compromised barrier does not only lose water. It loses the ability to control what enters. Irritants that would otherwise be filtered reach the living layers. And — critically — the barrier cells themselves, the keratinocytes, release inflammatory mediators in response to structural stress: cytokines, prostaglandins, and other signalling molecules that reach the melanocytes. The melanocytes respond.
Why barrier disruption sustains pigmentation recurrence
- Barrier disruption Stratum corneum lipid matrix is compromised — by UV, friction, aggressive actives, hard water, humidity cycling, or pollution.
- Keratinocyte stress response Stressed keratinocytes release inflammatory mediators — cytokines and prostaglandins — into the local skin environment.
- Melanocyte activation Inflammatory mediators reach the melanocytes at the base of the epidermis, triggering upregulated melanin synthesis.
- Pigment deposition Excess melanin is packaged into melanosomes and transferred to surrounding keratinocytes, becoming visible as dark marks as cells migrate to the surface.
- Aggressive treatment re-disrupts the barrier Strong tyrosinase inhibitors, acids, and retinoids applied to address the visible pigment further disrupt the barrier — restarting the cycle from step one.
When we were developing FIKA, the question that kept coming back was: why does the standard approach — a tyrosinase inhibitor and an acid — work initially and then stop? The answer, when you look at the biology, is that the treatment and the trigger are running simultaneously. The treatment suppresses melanin production; the actives in the same routine are disrupting the barrier and reactivating the inflammatory signal. You are essentially accelerating with one foot and braking with the other. The formulation needed to interrupt the cycle, not just suppress its output. That meant the barrier had to be part of the architecture.
This cycle is why the environment Indian skin actually lives in matters so much. High UV load, visible light, heat, urban pollution, hard water, air conditioning cycling between extremes of humidity — each of these is a low-grade stressor. Together, they constitute a chronic barrier challenge that the skin never fully recovers from between rounds. The barrier is under continuous pressure. In this context, adding aggressive depigmenting actives that further challenge barrier integrity is not a neutral act. It adds to the load.
Most of what gets called a pigmentation problem is, in many cases, a barrier problem expressing itself as pigmentation. The distinction is not academic. It changes what the treatment should do.
Why Treatment Often Fails
The standard depigmenting routine — a strong tyrosinase inhibitor, a retinoid or acid, and sunscreen — was designed around a model built for lighter phototypes dealing predominantly with UV-driven pigmentation. For those phototypes, in that context, it is a reasonable approach.
For Indian skin, in the environment Indian skin actually lives in, this architecture has a specific failure mode. The actives that are strong enough to produce visible depigmentation in melanin-rich skin are often strong enough to disrupt the barrier in reactive skin. Barrier disruption triggers the inflammatory response that activates the melanocyte. The melanocyte produces more melanin. The very process the treatment was trying to interrupt is re-triggered by the treatment itself.
| What the approach addresses | Removal-focused approach | Cycle-interrupting approach |
|---|---|---|
| Visible pigment (melanin already deposited) | Yes — tyrosinase inhibition, exfoliation | Yes — tyrosinase modulation, turnover support |
| Melanocyte activation signal (the upstream trigger) | Not addressed | Yes — upstream signalling inhibitors (e.g. Nonapeptide-1) |
| Melanosome transfer to keratinocytes | Rarely addressed | Yes — transfer inhibition (e.g. Niacinamide) |
| Barrier integrity (which feeds the inflammatory signal) | Often compromised by the actives used | Yes — ceramides, fatty acids as structural components |
| Risk of treatment-induced recurrence | High — barrier disruption re-activates the cycle | Lower — barrier support reduces re-activation risk |
| Long-term recurrence pattern | Improvement, then return | Reduced trigger load over time |
This is not a theoretical concern. It is the pattern that comes up again and again in Indian skin communities: a strong product, initial improvement, and then the skin becoming more reactive, more prone to new marks, until it returns to where it was — or somewhere worse. The product worked. And then it worked against itself.
The other failure mode is more straightforward: treatment that produces improvement while active does not produce change in the trigger landscape. Melanocyte reactivity is unchanged. The inflammatory pathways that produced the original pigmentation are unchanged. The environmental load is unchanged. When treatment stops — for any reason — the skin returns to the state it was always in. Because nothing about that state was addressed.
Why Sunscreen Alone Is Not Always Enough
Sunscreen matters. Nothing that follows is an argument against it. But it has become such an absolute recommendation that a large proportion of Indian women using it diligently are confused about why it is not working well enough.
Sunscreen addresses UV — specifically UVB and, with broad-spectrum formulations, UVA. It does not filter visible light at meaningful levels. It does not address heat-mediated melanocyte activation via infrared. It does not address pollution-driven oxidative stress. And it does not address any of the post-inflammatory triggers — acne, friction, routine-induced irritation — that are often the primary drivers of pigmentation in Indian skin.
- UVB radiation — addressed by all SPF-rated sunscreens
- UVA radiation — addressed by broad-spectrum formulations
- High-energy visible light (HEV / blue light) — not meaningfully filtered by standard sunscreen. Tinted mineral sunscreens with iron oxides offer partial protection.
- Infrared radiation (heat) — not filtered by sunscreen; activates melanocytes via heat shock proteins
- Urban air pollution (particulate matter) — not filtered by sunscreen; triggers oxidative stress and inflammatory melanocyte signalling
- Post-inflammatory triggers (acne, friction, routine irritation) — not addressed by sunscreen; require anti-inflammatory and barrier-supporting intervention
For someone whose pigmentation is predominantly UV-driven — sun patches, holiday darkening, consistent outdoor exposure — daily SPF is the most important intervention. For someone whose primary source of pigmentation is acne-driven PIH, reactive skincare, or the broader environmental load of Indian urban life, sunscreen is necessary but not sufficient. It does not reach the triggers that are actually producing the pigment.
What Effective Pigmentation Management Actually Requires
This is where the different framing actually changes what you do.
If pigmentation is a recurrence problem — if the pigment visible on the skin surface is the output of an ongoing signalling process, not a fixed deposit waiting to be removed — then effective management requires intervening in the system that produces pigment, not only in the pigment itself.
That means addressing the upstream signal — the inflammatory pathway that activates the melanocyte before any melanin has been made. Intervening here means less melanin is triggered into production in the first place. That is a different intervention from suppressing tyrosinase after the order to produce melanin has already been placed.
It means supporting barrier integrity as a structural component of pigmentation management, not as a comfort consideration. A skin that cannot maintain its barrier will keep generating the inflammatory signals that produce pigmentation. Barrier lipids — ceramides, fatty acids, cholesterol — are not softening agents added to make a serum feel nicer. They are structural inputs that allow the skin to complete its own repair cycle, reducing the inflammatory burden that drives melanocyte overactivation.
It means distributing intervention across multiple points in the pigmentation pathway simultaneously — upstream signalling, tyrosinase regulation, melanosome transfer — rather than loading a single active at a high concentration and hoping the intensity compensates for the narrowness of the intervention. In eumelanin-rich, barrier-vulnerable skin, high concentrations of single actives carry the risk of barrier disruption and inflammatory rebound.
What we kept coming back to was this: Indian skin's reactivity is not a condition to be cured. There is no formulation that removes it. What is possible — and this matters — is reducing the trigger load enough that the skin no longer needs to respond the way it has been. That the skin returns to a baseline from which it responds proportionately, rather than disproportionately, to the signals it encounters. That was the design brief for FIKA. Not to produce the fastest visible result. But to interrupt the cycle at enough points that the result, when it came, would stay.
FIKA was not formulated as the strongest available tyrosinase inhibitor. It was formulated around the specific observation that in Indian skin, pigmentation is almost always inseparable from barrier instability, chronic low-grade inflammation, and melanocyte overreactivity. The ingredient architecture distributes intervention across the full pigmentation pathway.
- Upstream signalling Nonapeptide-1, Bidens pilosa — interrupt melanocyte activation before melanin synthesis begins
- Melanogenesis modulation Oxyresveratrol — tyrosinase regulation at the synthesis stage
- Melanosome transfer Niacinamide — inhibits transfer of melanosomes from melanocyte to keratinocyte
- Barrier resilience Ceramides and fatty acids — structural support to reduce barrier-disruption-driven inflammatory signalling
- Antioxidant support Addresses oxidative stress as a melanogenic trigger in the Indian urban exposome
If you want to understand the mechanism in more detail, or explore specific aspects of pigmentation in Indian skin, the pages below extend each part of what has been covered here.
Frequently Asked Questions
Why does my pigmentation come back after I stop using a serum?
Depigmenting serums suppress melanin production or accelerate the shedding of pigmented cells while they are in use. They do not change the underlying trigger — the inflammatory signal that tells the melanocyte to produce more melanin. When the serum stops, the suppression stops. The trigger, which was running throughout, resumes producing pigment without the suppression. This is not a product failure; it is a category-level framing problem. Products designed around removal do not change the inputs that generate the output.
Is Indian skin more prone to pigmentation than other skin types?
Yes — specifically to post-inflammatory hyperpigmentation. Melanocytes in Fitzpatrick IV–VI skin are more reactive to inflammatory signals: they respond to a wider range of inputs and respond more intensely than melanocytes in lighter skin experiencing the same trigger. Melanosomes are also larger in darker skin and distribute more widely through keratinocytes, making marks appear more intensely and persist longer. These are biological characteristics, not signs of damaged or unhealthy skin. They do require a different treatment approach from what most products were designed around.
I use sunscreen every day but my pigmentation keeps returning. Why?
Sunscreen addresses UV radiation — UVB and, with broad-spectrum formulations, UVA. It does not meaningfully filter high-energy visible light (HEV), which activates melanocyte signalling in melanin-rich skin through a UV-independent mechanism. It does not address heat-mediated activation via heat shock proteins, or oxidative stress from air pollution. And it does not address post-inflammatory triggers — acne, friction, or routine-induced barrier disruption — which are often the primary drivers of pigmentation recurrence in Indian skin. For many people, the triggers producing their pigmentation are not the ones sunscreen is designed to reach.
What is the difference between PIH and melasma, and does it matter for treatment?
PIH (post-inflammatory hyperpigmentation) is triggered by inflammation — a pimple, a wound, a product reaction, friction. Melasma is hormonally influenced — often connected to oestrogen changes from pregnancy, hormonal contraception, or perimenopause — and typically appears in a characteristic pattern on the cheeks, upper lip, and forehead. The distinction matters because the trigger is different. PIH can be significantly reduced by managing the inflammatory inputs. Melasma requires hormonal and photoprotective intervention in addition to melanogenesis support. In Indian skin, both are common and both can coexist, which is why distinguishing them matters for choosing the right approach.
Can skincare actives make pigmentation worse?
Yes — in specific conditions. Retinoids, high-concentration AHAs, and physical exfoliants can disrupt the stratum corneum's lipid matrix in reactive skin. That disruption triggers an inflammatory response from stressed keratinocytes, which releases signalling molecules that reach the melanocytes and upregulate melanin production. In Fitzpatrick IV–VI skin, this melanocyte activation produces visible pigmentation. The result is a pattern where the product initially improves pigmentation, then the skin becomes more reactive and new marks appear. The product did what it was designed to do; the barrier disruption produced an unintended downstream effect.
How long does it take to see improvement in post-inflammatory hyperpigmentation?
Pigment deposited during an inflammatory event is carried in keratinocytes that migrate from the base of the epidermis to the surface over approximately four to six weeks. This natural cell turnover rate sets a floor for how quickly surface pigmentation can fade without additional intervention. Consistent anti-inflammatory and melanogenesis-modulating treatment can shorten this timeline, but cannot change the underlying biology of cell turnover. In practice, visible improvement in PIH typically appears between six and twelve weeks of consistent use — with the caveat that if the inflammatory trigger is still active, new pigmentation will continue to be deposited while old pigment is clearing.
What ingredients should I look for in a pigmentation serum for Indian skin?
For Indian skin specifically, the formulation logic matters more than the ingredient list. Seek a serum that addresses multiple points in the pigmentation pathway — upstream melanocyte activation, melanin synthesis, and melanosome transfer — rather than concentrating on a single high-dose tyrosinase inhibitor. Barrier-supporting ingredients (ceramides, fatty acids) should be present as structural components, not afterthoughts. Anti-inflammatory inputs reduce the background signal that keeps the melanocyte chronically activated. And the overall actives load should be calibrated to reduce barrier disruption risk rather than maximise individual ingredient concentration.
Does pollution cause pigmentation in Indian skin?
Yes — through oxidative stress and the inflammatory cascade it triggers. Particulate matter from urban air pollution settles on the skin surface and generates reactive oxygen species that trigger the same keratinocyte-to-melanocyte inflammatory signalling as UV radiation and physical trauma — through a different pathway. For urban Indian skin, pollution constitutes a low-grade chronic stressor that contributes to the overall inflammatory load. It is one of several environmental triggers — alongside visible light and heat — that sunscreen does not address, and that are particularly relevant in the context of Indian city life.
- Kang, H.Y., & Ortonne, J.P. "What Should Be Considered in Treatment of Melasma." Annals of Dermatology, Vol. 22, No. 4, 2010, pp. 373–378. [melanocyte reactivity in darker phototypes; melanosome distribution]
- Quevedo, W.C., Szabó, G., & Virks, J. "Influence of Age and UV on the Population of DOPA-positive Melanocytes in Human Skin." Journal of Investigative Dermatology, Vol. 52, No. 3, 1969, pp. 287–290. [melanosome distribution and eumelanin persistence]
- Regazzetti, C., et al. "Melanocytes Sense Blue Light and Regulate Pigmentation through Opsin-3." Journal of Investigative Dermatology, Vol. 138, No. 1, 2018, pp. 171–178. [visible light / HEV as melanogenic trigger in melanin-rich skin]
- Mahmoud, B.H., et al. "Impact of Long-Wavelength UVA and Visible Light on Melanocompetent Skin." Journal of Investigative Dermatology, Vol. 130, No. 8, 2010, pp. 2092–2097. [visible light pigmentation in Fitzpatrick IV–VI skin]
- Trautinger, F. "Heat shock proteins in the photobiology of human skin." Journal of Photochemistry and Photobiology B: Biology, Vol. 63, 2001, pp. 70–77. [heat shock protein pathway and melanocyte activation]
- Grimes, P.E. "Management of Hyperpigmentation in Darker Racial Ethnic Groups." Seminars in Cutaneous Medicine and Surgery, Vol. 28, 2009, pp. 77–85. [PIH in Fitzpatrick IV–VI; treatment considerations for melanin-rich skin]
- Rawlings, A.V., & Harding, C.R. "Moisturization and skin barrier function." Dermatologic Therapy, Vol. 17, 2004, pp. 43–48. [barrier lipid architecture; ceramides, cholesterol, fatty acids]
- Davis, E.C., & Callender, V.D. "Postinflammatory Hyperpigmentation: A Review of the Epidemiology, Clinical Features, and Treatment Options in Skin of Color." Journal of Clinical and Aesthetic Dermatology, Vol. 3, No. 7, 2010, pp. 20–31. [PIH epidemiology and treatment failure patterns in skin of colour]